Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Clinical trial NCT03875313 · TERMINATED
Trial details
- NCT number
- NCT03875313
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-20
- Primary completion
- 2020-07-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.